CausalSentinel

Protein Dossier — AHSG (Alpha-2-HS-glycoprotein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: diverticular disease or diverticulitis 0.102 0.0367 0.00566 Wald ratio 1 cis NA
Endometrioid ovarian cancer 0.121 0.0524 0.0207 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter -0.135 0.0588 0.0213 Wald ratio 1 cis NA
Paget’s disease 0.259 0.117 0.0269 Wald ratio 1 cis NA
Non-cancer illness code self-reported: ankylosing spondylitis -0.228 0.103 0.0274 Wald ratio 1 cis NA
Lumbar spine bone mineral density 0.0345 0.0158 0.0294 Wald ratio 1 cis NA
Non-cancer illness code self-reported: bladder problem (not cancer) 0.11 0.0506 0.0296 Wald ratio 1 cis NA
Fractured bone site(s): Ankle 0.0735 0.0341 0.0313 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years 0.0277 0.013 0.0336 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypopituitarism 0.35 0.17 0.04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.0896 0.0436 0.0401 Wald ratio 1 cis NA
Type 2 diabetes 0.0627 0.0314 0.0457 Wald ratio 1 cis NA
…and 94 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3581_53_3 a2-HS-Glycoprotein Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

117 association rows across 95 traits (114 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Alpha-2-HS-glycoprotein (analyte X10966.1) levels 5e-1417 rs4917 1 GCST90421283 no MR -> candidate analysis
AHSG protein levels 2e-211 rs140827890 7 GCST90468263 no MR -> candidate analysis
Alpha-2-HS-glycoprotein level in Chronic kidney disease with 3e-197 rs4917 1 GCST90233040 no MR -> candidate analysis
Circulating ENTPD5 levels 3e-144 rs35457250 1 GCST90860373 no MR -> candidate analysis
ENTPD5 protein levels 6e-118 rs35457250 1 GCST90469121 no MR -> candidate analysis
Serum calciprotein particle maturation time (T50) 2e-101 rs4917 1 GCST90102513 no MR -> candidate analysis
PINLYP protein levels 3e-90 rs35457250 1 GCST90470238 no MR -> candidate analysis
PDZK1 protein levels 3e-78 rs1900618 2 GCST90470203 no MR -> candidate analysis
Glycoprotein acetyls levels 4e-77 rs4918 4 GCST90501111 no MR -> candidate analysis
Protein FAM210A protein levels (SomaScan ID:10966-1) 3e-75 rs4917 1 GCST90442358 no MR -> candidate analysis
PXK protein levels 2e-71 rs4918 1 GCST90453317 no MR -> candidate analysis
VWA1 protein levels 2e-58 rs35457250 1 GCST90471061 no MR -> candidate analysis
…and 83 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1892 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Alopecia-intellectual disability syndrome 0.561 established (curated) no MR -> candidate analysis
otosclerosis 0.718 common-variant locus no MR -> candidate analysis
alopecia - intellectual disability syndrome 0.608 established (curated) no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Alpha-2-HS-glycoprotein)
gnomAD constraint pLI=8.5e-07, LOEUF=1.08 — LoF-tolerant
GWAS Catalog 179 unique SNPs / 458 rows
ClinVar 123 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance